- Home
- AXSM vs LGND Comparison
AXSM vs LGND Comparison
Compare AXSM & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AXSM | LGND |
|---|---|---|
| Founded | 2012 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.3B | 6.0B |
| IPO Year | 2015 | 1997 |
Fundamental Metrics
Financial Performance| Metric | AXSM | LGND |
|---|---|---|
| Price | $146.09 | $319.33 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 22 | 11 |
| Target Price | $265.86 | ★ $361.27 |
| AVG Volume (30 Days) | ★ 1.0M | 183.8K |
| Earning Date | 11-02-2026 | 10-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 38.56 | ★ 2886.36 |
| EPS | N/A | ★ 0.31 |
| Revenue | N/A | ★ $141,102,000.00 |
| Revenue This Year | $49.13 | $8.82 |
| Revenue Next Year | $52.20 | $31.67 |
| P/E Ratio | ★ N/A | $1,028.35 |
| Revenue Growth | N/A | ★ 29.48 |
| 52 Week Low | $123.00 | $175.89 |
| 52 Week High | $260.19 | $326.63 |
Technical Indicators
Market Signals| Indicator | AXSM | LGND |
|---|---|---|
| Relative Strength Index (RSI) | 43.74 | 57.22 |
| Support Level | $123.00 | $277.97 |
| Resistance Level | $169.11 | $319.83 |
| Average True Range (ATR) | 7.45 | 11.68 |
| MACD | 2.39 | 0.16 |
| Stochastic Oscillator | 79.51 | 76.58 |
Price Performance
Historical ComparisonAbout AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About LGND Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.